Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Oesophageal carcinoma

H. Kato, T. Miyazaki, M. Nakajima, M. Fukuchi, R. Manda, H. Kuwano, Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma, Br. J. Surg. 91(8) (2004) 1004-1009. [Pg.187]

Jalan, R., Hayes, P.C., Morris, AJ., Jenkins, S., Krasner, N., Shieids, R., Lombard, M., Waiker, R.J. Oesophageal variceal sclerotherapy a risk factor for the development of oesophageal carcinoma. Dis. Esophagus 1993 4 51-53... [Pg.370]

Fig. 37.29 Laparoscopic staging metastases at the falciform ligament in oesophageal carcinoma... Fig. 37.29 Laparoscopic staging metastases at the falciform ligament in oesophageal carcinoma...
Erbstatin showed an antitumour effect on human carcinomas transplanted in nude mice (17). Human breast carcinoma MCF-7 cells have EGF receptors. Erbstatin inhibited the growth of MCF-7 in mice when administered along with foroxymithine, which is a ferric ion chelator that protects erbstatin in serum. Erbstatin also had an antitumour effect on human oesophageal carcinoma EH-4 (17). 2,5-MeC inhibited the growth of MCF-7 in nude mice without foroxymithine (M. Toi, unpublished result). [Pg.449]

Kelly, S., Harris, K., Berry, E. et al., A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut, 49, 534-539,2001. [Pg.186]

In black males who died of oesophageal carcinoma, hepatic iron concentrations were significantly higher than those of males in the same age groups who died of other causes (MacPhail etal. 1979). [Pg.720]

Sanyika C, Corr P, Haffejee A (1999) Palliative treatment of oesophageal carcinoma - efficacy of plastic versus self-expandable stents. SAMJ 89 640-643 Saxon RR, Barton RE, Rosch J (1994) Complications of oesophageal stenting and balloon dilatation. Semin Intervent Radiol 11 276-282... [Pg.48]

Tytgat GN (1990) Endoscopic review of esophageal cancer possibilities and limitations. Endoscopy 22 263-267 Watkinson AF, Ellul J, Entwisle K, et al. 0995a) Oesophageal carcinoma initial results of palliative treatment with covered self-expanding endoprostheses. Radiology 195 821-827... [Pg.48]

Watson A (1982) A study of the quality and duration of survival following resection, endoscopic intubation and surgical intubation in oesophageal carcinoma. Br J Surg 69 585-588... [Pg.48]

This is mainly a classification of active disease and does not take complications of gastro-oesophageal reflux disease into account, i.e. scar formation and strictures. In dysphagic patients with no other symptom or sign of reflux oesophagitis, carcinoma of the oesophagus must be excluded. [Pg.34]

The incidence of adenocarcinoma has increased during the last decades and it numbers almost 20% of all oesophageal carcinomas. The majority of adenocarcinomas arise at the oesophago-gastric junction. Second types of adenocarcinoma are associated with Barrett s oesophagus, and arise from the level of the displaced transition zone. [Pg.37]

Submucosal lesions in the oesophagus are also encountered, a relatively rare one being intramural pseudodiverticulosis (Flora et al. 1997) (Fig. 4.26). This is a condition of unknown aetiology, but which has an association with diabetes, alcohol abuse, reflux disease, and oesophageal strictures. It is more commonly seen in patients with oesophageal carcinomas than in matched controls, and there... [Pg.82]

Fig. 6.2.14a,b. Direct invasion of the stomach by neighbouring tumour, a Oblique coronal reformation through the pancreas demonstrates the direct invasion of the stomach by an adenocarcinoma of the pancreatic tail (arrow). There is a splenic infarct (white arrowhead) and splenic hypoperfusion (black arrowhead) due to tumour obstruction of the splenic artery and vein, b Parasagittal reformation through the gastroesophageal junction demonstrates surgical proved direct infiltration of the stomach by oesophageal carcinoma (arrows)... [Pg.138]

Arnott SJ, Duncan W, Gignoux M, et al. Preoperative radiotherapy in esophageal carcinoma a metaanalysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 1998 41(3)379-583. [Pg.232]

Overexpression of the EGF receptor (or any of its ligands), can also induce cancer in both cell lines and transgenic animal models. Monoclonal antibodies capable of blocking receptor activity can promote tumour regression in mice suffering from various carcinomas. A direct correlation also exists between elevated EGF receptor numbers and a shorter patient survival span in the case of several forms of breast, oesophageal, bladder and squamous cell carcinomas. [Pg.287]

Uchida, S., Shimada, Y, Watanabe, G., Li, Z. G., Hong, T., Miyake, M. and Imamura, M. (1999). Motility-related protein (MRP-1/CD9). and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br. J. Cancer 79, 1168-1173. [Pg.339]

Arsenic Arsenic poisoning is of great medicohistorical interest, (s. p. 564) Chronic arsenic intoxication can be caused by inhalation or, more often, by oral uptake. Steatosis and cell necrosis occur in the liver fibrosis or cirrhosis with portal hypertension and oesophageal varices develop. The presence of liver adenoma and VOD as well as hver carcinoma or haemangioendothelioma has been described. (16, 42, 50, 53, 60, 76)... [Pg.569]

Nemoto, T., Terashima, S., Kogure, M., Hoshino, Y., Kusakabe, T., Suzuki, T. and Gotoh, M., Overexpression of fatty acid synthase in oesophageal squamous cell dysplasia and carcinoma, Pathobiology 69 (2001) 297-303. [Pg.190]

Data on two of these new taxanes, namely BMS-184476 (29) and BMS-188797 (29a), were published by Bristol-Myers-Squibb (BMS), which also developed Paclitaxel [96]. In a comparative preclinical study, both analogues were found to have cytotoxic potency similar to Paclitaxel but overcome two different forms of Paclitaxel resistance. BMS-184476 was found to be clearly superior to Paclitaxel especially on A2780 ovarian carcinoma, HCT/pk, a moderately Paclitaxel-resistant colon carcinoma and L2987 lung carcinoma. BMS 184476 is currently in phase II clinical trials in breast, NSCLC, oesophageal and gastrointestinal cancers [97]. [Pg.739]


See other pages where Oesophageal carcinoma is mentioned: [Pg.186]    [Pg.695]    [Pg.1122]    [Pg.632]    [Pg.7]    [Pg.697]    [Pg.237]    [Pg.48]    [Pg.608]    [Pg.138]    [Pg.186]    [Pg.695]    [Pg.1122]    [Pg.632]    [Pg.7]    [Pg.697]    [Pg.237]    [Pg.48]    [Pg.608]    [Pg.138]    [Pg.321]    [Pg.437]    [Pg.661]    [Pg.909]    [Pg.635]    [Pg.635]    [Pg.319]    [Pg.54]    [Pg.66]    [Pg.631]    [Pg.356]    [Pg.521]    [Pg.564]    [Pg.568]    [Pg.663]    [Pg.26]    [Pg.32]    [Pg.130]    [Pg.130]    [Pg.532]    [Pg.693]   
See also in sourсe #XX -- [ Pg.2871 ]




SEARCH



Oesophagitis

© 2024 chempedia.info